JFNIX
Price
$74.71
Change
+$0.48 (+0.65%)
Updated
Oct 8 closing price
Net Assets
4.49B
LHCCX
Price
$19.77
Change
+$0.14 (+0.71%)
Updated
Oct 8 closing price
Net Assets
8.12M
Interact to see
Advertisement

JFNIX vs LHCCX

Header iconJFNIX vs LHCCX Comparison
Open Charts JFNIX vs LHCCXBanner chart's image
Janus Henderson Global Life Sciences I
Price$74.71
Change+$0.48 (+0.65%)
VolumeN/A
Net Assets4.49B
Lord Abbett Health Care C
Price$19.77
Change+$0.14 (+0.71%)
VolumeN/A
Net Assets8.12M
JFNIX vs LHCCX Comparison Chart in %
View a ticker or compare two or three
VS
JFNIX vs. LHCCX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and LHCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.49B vs. LHCCX (8.12M). JFNIX pays higher dividends than LHCCX: JFNIX (0.38) vs LHCCX (0.00). JFNIX was incepted earlier than LHCCX: JFNIX (16 years) vs LHCCX (6 years). LHCCX (4.09) is less costly to investors than JFNIX (0.77). LHCCX is a more actively managed with annual turnover of: 88.00 vs. JFNIX (35.00). LHCCX has a lower initial minimum investment than JFNIX: LHCCX (1500) vs JFNIX (2500). LHCCX annual gain was more profitable for investors over the last year : 2.72 vs. JFNIX (-6.30). JFNIX return over 5 years is better than : 8.06 vs. LHCCX (-3.77).
JFNIXLHCCXJFNIX / LHCCX
Total Expense Ratio0.771.7843%
Annual Report Gross Expense Ratio0.774.0919%
Fund Existence16 years6 years-
Gain YTD9.1306.685137%
Front LoadN/AN/A-
Min. Initial Investment25001500167%
Min. Initial Investment IRAN/AN/A-
Net Assets4.49B8.12M55,234%
Annual Yield % from dividends0.380.00-
Returns for 1 year-6.302.72-232%
Returns for 3 years24.2924.40100%
Returns for 5 years8.06-3.77-214%
Returns for 10 years41.04N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEKAX22.55N/A
N/A
DWS Emerging Markets Equity A
TOLSX16.88N/A
N/A
DWS RREEF Global Infrastructure S
CHCZX13.66N/A
N/A
AB Discovery Growth Z
FCPAX35.41N/A
N/A
Fidelity Advisor Intl Capl App A
SPVYX23.75N/A
N/A
SEI Small Cap Value Y (SIMT)